4.7 Review

CRISPR/Cas9 in the era of nanomedicine and synthetic biology

期刊

DRUG DISCOVERY TODAY
卷 28, 期 1, 页码 9-14

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2022.103375

关键词

Genome editing; Nanomedicine; Synthetic biology; Nanogenetics

向作者/读者索取更多资源

The CRISPR/Cas system, originally discovered as a defense mechanism in bacteria, is now being used as a precise gene editing tool. Safety, specificity, and delivery concerns limit its potential. The concept of nanogenetics is introduced as a way to advance the biomedical field through the rational engineering of the CRISPR/Cas machinery, enabling the design of safer and more specific genome editing platforms.
The CRISPR/Cas system was first discovered as a defense mechanism in bacteria and is now used as a tool for precise gene-editing applications. Rapidly evolving, it is increasingly applied in therapeutics. However, concerns about safety, specificity, and delivery still limit its potential. In this context, we introduce the concept of nanogenetics and speculate how the rational engineering of the CRISPR/Cas machinery could advance the biomedical field. In nanogenetics, the advantages of traditional approaches of synthetic biology could be expanded by nanotechnology approaches, enabling the design of a new generation of intrinsically safe and specific genome-editing platforms.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据